BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38191717)

  • 1. Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma.
    Qi F; Wei Y; Wu M; Sun Y; Xie Y; Lin N; Liu W; Wang W; Song Y; Zhu J
    Ann Hematol; 2024 May; 103(5):1643-1653. PubMed ID: 38191717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.
    Yang J; Li P; Piao Y; Liu X; Wei L; Sang W; Zhang L; Wang L
    Front Immunol; 2022; 13():829366. PubMed ID: 35371002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
    Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term effect of risk-adaptive therapy for early stage extranodal NK/T cell lymphoma].
    Wu T; Liu QL; Hu YF; Zhang J; Chen MX; Chen XX; Huang YH; Lu B
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):859-864. PubMed ID: 31770855
    [No Abstract]   [Full Text] [Related]  

  • 5. Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation.
    Qi F; Zhou W; Xie Y; Sun Y; Wu M; Chai Y; Chen B; Lin N; Liu W; Ding N; Li Y; Dong M; Song Y; Zhu J
    Aging (Albany NY); 2022 Nov; 14(21):8729-8744. PubMed ID: 36326691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.
    Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY
    Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Shin HJ; Kim DY; Chung J; Shin KH; Lee H
    Acta Haematol; 2021; 144(4):427-437. PubMed ID: 33271543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience.
    Liu ZL; Bi XW; Zhang XW; Lei DX; Liu PP; Yang H; Gao Y; Jiang YX; Jiang WQ; Xia Y
    Cancer Res Treat; 2019 Oct; 51(4):1557-1567. PubMed ID: 30971067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features and treatment outcome of extranodal nasal-type NK/T-cell lymphoma of the extra-upper aerodigestive tract].
    Zhao YT; Wang Y; Qi SN; Yang Y; He X; Zhang YJ; Huang HQ; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhu Y; Cao JZ; Wu JX; Wu T; Zhu SY; Shi M; Xu LM; Yuan ZY; Su H; Song YQ; Zhu J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):787-794. PubMed ID: 34289574
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
    Wu RY; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Liu QF; Wang ZY; Qi SN; Lu NN; Chen B; Zhang XM; Zhou LQ; Liu XF; Yu ZH
    Am J Clin Oncol; 2014 Feb; 37(1):41-6. PubMed ID: 22992625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of Ku80 and PDGFR-α in nasal NK/T-cell lymphoma.
    Li J; Chen P; Liu W; Xia Z; Shi F; Zhong M
    Pathol Res Pract; 2016 Mar; 212(3):204-9. PubMed ID: 26778387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
    Lu L; Fu X; Li Z; Qiu Y; Li W; Zhou Z; Xue W; Wang Y; Jin M; Zhang M
    Biochem Biophys Res Commun; 2018 Oct; 504(2):525-531. PubMed ID: 30201265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of CD7 and its correlation with prognosis in patients with NK/T-cell lymphoma].
    Fu XR; Wan WJ; Sun ZC; Zhang XD; Nan FF; Ge JR; Xia YQ; Zhang MZ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):921-926. PubMed ID: 33333695
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
    Yamaguchi M; Suzuki R; Miyazaki K; Amaki J; Takizawa J; Sekiguchi N; Kinoshita S; Tomita N; Wada H; Kobayashi Y; Niitsu N; Ando T; Maeda T; Saito B; Matsuoka H; Sakai R; Kubota N; Masaki Y; Kameoka Y; Asano N; Oguchi M; Katayama N
    Ann Hematol; 2019 Jul; 98(7):1647-1655. PubMed ID: 31001658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma.
    Chai Y; Qi F; Chen B; Gui L; Yang J; Qi S; Song Y; Li Y; Wei Y; Dong M
    Ann Hematol; 2020 Jun; 99(6):1303-1309. PubMed ID: 32333152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1.
    Wang J; He AL; Zhang WG; Cao XM; Chen YX; Liu J; Zhao WH; Yang Y; Wang JL; Liu HL; Ma XR
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8057-8066. PubMed ID: 32767332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma.
    Sun Z; Wan W; Zhang X; Zhang L; Li X; Li L; Wang X; Nan F; Yu H; Chang Y; Yan J; Li Z; Cui F; Ge J; XiaXu YD; Xu X; Fu X; Zhang M
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3449-3459. PubMed ID: 35857124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Lin N; Ku W; Song Y; Zhu J; Lu Z
    Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of peripheral blood CD4+CD25+ regulatory T cell in patients with extranodal NK/T cell lymphoma, nasal type].
    Li X; Wang J; Cui X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):808-11. PubMed ID: 25246248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy.
    Wang ZY; Liu QF; Wang H; Jin J; Wang WH; Wang SL; Song YW; Liu YP; Fang H; Ren H; Wu RY; Chen B; Zhang XM; Lu NN; Zhou LQ; Li YX
    Blood; 2012 Sep; 120(10):2003-10. PubMed ID: 22826562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.